SAN MATEO, Calif., Feb. 29, 2012 (GLOBE NEWSWIRE) -- NeurogesX, Inc. (Nasdaq:NGSX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced it will hold a conference call on Thursday, March 8, 2012 at 8:30 a.m. ET (5:30 a.m. PT) to report results for its fourth quarter and year ended December 31, 2011.
